We've updated our Privacy Policy to make it clearer how we use your personal data. We use cookies to provide you with a better experience. You can read our Cookie Policy here.

Advertisement

Latest Industry Insights

Magnifying glass highlighting a yellow capsule among various blue and white pills during drug screening.
Industry Insight

From Hits to Leads: Improving Early Drug Discovery With Better Tools

In this interview, Dr. Iain Yisu Wang from MedChemExpress discusses the growing role of AI, the value of phenotypic screening and how tailored compound libraries are helping researchers keep up with the increasing complexity of drug discovery.
Digital drug capsule with circuit patterns releasing glowing particles, symbolizing AI.
Industry Insight

AI and Synthetic Biology: Balancing Innovation With Biosecurity

AI is revolutionizing biotechnology innovation, but industry stakeholders must work together to mitigate its risks. In this article, Adam Clore explores the role of nucleic acid biosecurity screening tools and how they can be improved.
Group of human cells floating on a light green background.
Industry Insight

From Policy to Practice: How Human-Based In Vitro Models Are Reshaping Discovery

Discover how scalable, human-based in vitro models are reshaping discovery pipelines, balancing complexity with reproducibility, and enabling new kinds of experimentation that go beyond the limits of animal research.
Five male and female cell and gene therapy scientists with their arms crossed.
Industry Insight

From Bench to Boardroom: Leading Cell and Gene Therapy Through Uncertainty

In this opinion piece, Dr. Stella Vnook explores how cell and gene therapy leaders are adapting to today’s financial and regulatory headwinds, offering actionable insights into how biotech CEOs are rethinking capital strategy.
Three scientists in lab coats discussing their research in a lab with lab glassware on the shelf behind them.
Industry Insight

Driving Innovation While Navigating Global Pressures: How One Life Science Company Is Evolving With the Market

As global scientific and regulatory landscapes shift, companies across the life sciences sector are under growing pressure to adapt. Hear how Phenomenex are taking a proactive approach.
A group of life scientists in lab coats facing the camera, arms crossed with challenging looks on their faces.
Industry Insight

Life Science Marketing: All You Need To Know

This article explores the unique characteristics and challenges of life sciences marketing, offering insights on how to achieve meaningful engagement with a highly specialized audience.
An individual wearing blue gloves and blue lab coat holding a white mouse.
Industry Insight

A New Era in Drug Discovery Begins as FDA Embraces Human Models

In this article, discover how the FDA and NIH are replacing animal testing with human models, such as organoids, featuring expert insights on safer, faster and ethical drug development.
A scientist holding up a vial containing a DNA double helix, representing cell and gene therapy manufacturing.
Industry Insight

FDA Delays Cell and Gene Therapy Approvals Following CMC Issues

Explore why cell and gene therapy manufacturing failures are now a leading cause of FDA rejections and how to avoid them.
A blue drug pill on top of a black switchboard, representing AI-driven drug discovery.
Industry Insight

Beyond Black-Box Models: Advances in Data-Driven ADMET Modeling

Discover how AI-powered ADMET modeling can enable the prediction of toxicity and pharmacokinetics with depth, transparency and scientific rigor.
A researcher in PPE holding a white mouse used for animal testing in drug discovery and development.
Industry Insight

Are Plans To Phase Out Animal Testing Realistic?

Cell models are replacing animal testing in pharma. Explore expert tips on transitioning to more accurate, ethical and scalable alternatives.
Advertisement